178 related articles for article (PubMed ID: 31395332)
21. Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity.
Barman-Aksoezen J; Girelli D; Aurizi C; Schneider-Yin X; Campostrini N; Barbieri L; Minder EI; Biolcati G
J Inherit Metab Dis; 2017 May; 40(3):433-441. PubMed ID: 28185024
[TBL] [Abstract][Full Text] [Related]
22. Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy.
Ventura P; Brancaleoni V; Di Pierro E; Graziadei G; Macrì A; Carmine Guida C; Nicolli A; Rossi MT; Granata F; Fiorentino V; Fustinoni S; Sala R; Pinton PC; Trevisan A; Marchini S; Cuoghi C; Marcacci M; Corradini E; Sorge F; Aurizi C; Savino MG; Cappellini MD; Pietrangelo A
Eur J Dermatol; 2020 Oct; 30(5):532-540. PubMed ID: 33021473
[TBL] [Abstract][Full Text] [Related]
23. Protoporphyrin IX in the skin measured noninvasively predicts photosensitivity in patients with erythropoietic protoporphyria.
Heerfordt IM; Wulf HC
Br J Dermatol; 2016 Dec; 175(6):1284-1289. PubMed ID: 27603594
[TBL] [Abstract][Full Text] [Related]
24. Trends in erythrocyte protoporphyrin IX concentration by age, sex and season among patients with erythropoietic protoporphyria-20 years of follow-up.
Heerfordt IM; Lerche CM; Wulf HC
Photodiagnosis Photodyn Ther; 2020 Dec; 32():101928. PubMed ID: 32717453
[TBL] [Abstract][Full Text] [Related]
25. A Novel Mutation in the FECH Gene in a Czech Family with Erythropoietic Protoporphyria and a Population Study of IVS3-48C Variant Contributing to the Disease.
Farrag MS; Kučerová J; Šlachtová L; Šeda O; Šperl J; Martásek P
Folia Biol (Praha); 2015; 61(6):227-32. PubMed ID: 26789144
[TBL] [Abstract][Full Text] [Related]
26. Protoporphyrin IX-induced phototoxicity: Mechanisms and therapeutics.
Hussain Z; Qi Q; Zhu J; Anderson KE; Ma X
Pharmacol Ther; 2023 Aug; 248():108487. PubMed ID: 37392940
[TBL] [Abstract][Full Text] [Related]
27. Inactivation of protoporphyrin IX in erythrocytes in patients with erythropoietic protoporphyria: A new treatment modality.
Wulf HC; Nissen CV; Philipsen PA
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101582. PubMed ID: 31809913
[TBL] [Abstract][Full Text] [Related]
28. Strong correlation of ferrochelatase enzymatic activity with Mitoferrin-1 mRNA in lymphoblasts of patients with protoporphyria.
Phillips J; Farrell C; Wang Y; Singal AK; Anderson K; Balwani M; Bissell M; Bonkovsky H; Seay T; Paw B; Desnick R; Bloomer J
Mol Genet Metab; 2019 Nov; 128(3):391-395. PubMed ID: 30391163
[TBL] [Abstract][Full Text] [Related]
29. Recognized and Emerging Features of Erythropoietic and X-Linked Protoporphyria.
Di Pierro E; Granata F; De Canio M; Rossi M; Ricci A; Marcacci M; De Luca G; Sarno L; Barbieri L; Ventura P; Graziadei G
Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054318
[TBL] [Abstract][Full Text] [Related]
30. Cimetidine Does Not Inhibit 5-Aminolevulinic Acid Synthase or Heme Oxygenase Activity: Implications for Treatment of Acute Intermittent Porphyria and Erythropoietic Protoporphyria.
Yasuda M; Lee S; Gan L; Bergonia HA; Desnick RJ; Phillips JD
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254627
[TBL] [Abstract][Full Text] [Related]
31. Mutation in human
Yien YY; Ducamp S; van der Vorm LN; Kardon JR; Manceau H; Kannengiesser C; Bergonia HA; Kafina MD; Karim Z; Gouya L; Baker TA; Puy H; Phillips JD; Nicolas G; Paw BH
Proc Natl Acad Sci U S A; 2017 Sep; 114(38):E8045-E8052. PubMed ID: 28874591
[TBL] [Abstract][Full Text] [Related]
32. Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyria.
Halloy F; Iyer PS; Ghidini A; Lysenko V; Barman-Aksözen J; Grubenmann CP; Jucker J; Wildner-Verhey van Wijk N; Ruepp MD; Minder EI; Minder AE; Schneider-Yin X; Theocharides APA; Schümperli D; Hall J
Cell Chem Biol; 2021 Aug; 28(8):1221-1234.e6. PubMed ID: 33756123
[TBL] [Abstract][Full Text] [Related]
33. Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.
Balwani M; Doheny D; Bishop DF; Nazarenko I; Yasuda M; Dailey HA; Anderson KE; Bissell DM; Bloomer J; Bonkovsky HL; Phillips JD; Liu L; Desnick RJ;
Mol Med; 2013 Apr; 19(1):26-35. PubMed ID: 23364466
[TBL] [Abstract][Full Text] [Related]
34. Modeling the ferrochelatase c.315-48C modifier mutation for erythropoietic protoporphyria (EPP) in mice.
Barman-Aksözen J; C Wiek P; Bansode VB; Koentgen F; Trüb J; Pelczar P; Cinelli P; Schneider-Yin X; Schümperli D; Minder EI
Dis Model Mech; 2017 Mar; 10(3):225-233. PubMed ID: 28093505
[TBL] [Abstract][Full Text] [Related]
35. Biochemical abnormality in erythropoietic protoporphyria: cause and consequences.
Bloomer JR; Wang Y; Singhal A; Risheg H
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S36-40. PubMed ID: 16819399
[TBL] [Abstract][Full Text] [Related]
36. Erythropoietic protoporphyria without skin symptoms-you do not always see what they feel.
Lecluse AL; Kuck-Koot VC; van Weelden H; Sigurdsson V; Russel IM; Frank J; Pasmans SG
Eur J Pediatr; 2008 Jun; 167(6):703-6. PubMed ID: 17710435
[TBL] [Abstract][Full Text] [Related]
37. Molecular epidemiology of erythropoietic protoporphyria in the U.K.
Whatley SD; Mason NG; Holme SA; Anstey AV; Elder GH; Badminton MN
Br J Dermatol; 2010 Mar; 162(3):642-6. PubMed ID: 20105171
[TBL] [Abstract][Full Text] [Related]
38. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H
Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323
[TBL] [Abstract][Full Text] [Related]
39. X-linked dominant protoporphyria: a new porphyria.
Seager MJ; Whatley SD; Anstey AV; Millard TP
Clin Exp Dermatol; 2014 Jan; 39(1):35-7. PubMed ID: 24131146
[TBL] [Abstract][Full Text] [Related]
40. Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria.
Eichbaum QG; Dzik WH; Chung RT; Szczepiorkowski ZM
Transfusion; 2005 Feb; 45(2):208-13. PubMed ID: 15660829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
